-- 美国全国房地产经纪人协会(NAR)周一公布的数据显示,3月份美国成屋销售速度经季节性调整后,年化率为398万套,较2月份的413万套下降3.6%,低于彭博社截至美国东部时间上午7:30汇总的调查预期值405万套。 总销售量同比下降1%。 NAR首席经济学家劳伦斯·云表示:“3月份房屋销售依然疲软,低于去年同期水平。消费者信心下降和就业增长放缓继续抑制购房者。” 独栋住宅销售量下降3.5%,公寓销售量下降5.4%。 与上月相比,全国所有四个地区的销售量均有所下降。与去年同期相比,中西部和东北部地区的销售量下降,而南部和西部地区的销售量则有所增长。 房屋在市场上停留的中位数为 41 天,低于 2 月份的 47 天,高于去年同期的 36 天。 3 月份待售房屋供应量从 2 月份的 132 万套增至 136 万套,比去年同期的 133 万套增长了 2.3%。 房屋在市场上的供应量从 2 月份的 3.8 个月增至 4.1 个月,比去年同期的 4.0 个月有所增加。 房屋价格中位数从 39.8 万美元上涨至 40.88 万美元,比去年同期的 40.31 万美元上涨了 1.4%,创下 3 月份的历史最高纪录。 美国房地产经纪人协会 (NAR) 大幅下调了 2026 年成屋销售增长预期,从之前的 14% 降至 4%。 “抵押贷款利率持续上涨,导致我们下调了今年的房屋销售预期,”Yun表示。“即使销售增长速度放缓,由于库存增长缓慢,房价仍持续稳步上涨。” 美国房地产经纪人协会(NAR)发布的月度二手房销售报告衡量的是单户和多户住宅在成交时的销售情况,包括现有房屋数量和销售中位价。强劲的销售数据对抵押贷款机构和相关消费品公司来说都是利好消息。
Related Articles
Research Alert: CFRA Keeps Buy Opinion On Shares Of The Hartford Insurance Group, Inc.
CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We trim our 12-month target price by $8 to $155, valuing HIG shares at 11.3x our 2026 operating EPS estimate of $13.75 (cut by $0.45) and at 10.6x our 2027 EPS estimate of $14.65 (cut by $0.30), vs. the shares' one-year average forward multiple of 10.3x and peer average of 13x. Q1 EPS of $3.09 vs. $2.20 a year ago missed our $3.60 estimate and $3.39 consensus view. Operating revenue growth of 6.2% was in line with our 6%-10% forecast, amid 5.3% earned premium growth, 13% higher net investment income, and 7.9% fee revenue growth. Q1 written premium growth of 4% and full-year 2025 growth of 7% bode well for 2026 revenue trends as premiums are earned. Underwriting results improved significantly, with Personal Lines combined ratio improving to 87.7% from 106.1% and underlying combined ratio to 85.0% from 89.7%. Business Insurance combined ratio was stable at 94.8%. Weighing the Q1 EPS miss with HIG's decent top-line growth and discounted valuation to peers, we view the shares as undervalued.
Research Alert: CFRA Keeps Strong Buy Opinion On Shares Of Baker Hughes
CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We raise our 12-month target price by $14 to $82, reflecting a combination of our sum-of-the-parts (SOTP) and DCF models. For our SOTP model, we presume the oilfield services business (about 50% of BKR's franchise) to be valued at about 10x projected 2027 EBITDA (in line with major peers) and its industrial energy technology business (the other 50%) valued at 14x projected 2027 EBITDA (in line with the peer median). This blended approach, yielding a 12x multiple, implies a value of $73 per share. Meanwhile, our DCF model, using medium-term free cash flow growth of 5% per year, terminal growth of 2.5%, discounted at a WACC of 6.3%, yields intrinsic value of $91 per share. We cut our 2026 EPS estimate by $0.47 to $2.48, but we raise 2027's by $0.07 to $3.24. We acknowledge that the oilfield services business is likely to struggle in 2026 owing to the U.S.-Iran conflict, but the IET business appears quite robust and likely to be a source of both accelerating revenue growth and margins.
Research Alert: CFRA Maintains Hold Opinion In Shares Of Wab
CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We lift our 12-month target to $285 from $275 following WAB's Q1 earnings print, valuing shares at 24.2x our 2027 EPS outlook of $11.76 (revised from $11.46; 2026 EPS estimate up to $10.57 from $10.50), a slight premium to WAB's long-term historical multiple average given structural improvements in earnings quality. While we are cautious on signs of overcapacity in the freight market, an elevated order backlog (12-month sits at over $9 billion), internal initiatives to shore up margins, and potential synergies from M&A activity positions WAB to continue growing earnings at double-digit rates in 2026-2027, in our view. Despite tariff-related cost pressures, WAB has done a commendable job of defending margins via a mix of pricing, lean manufacturing, and pruning of lower-profit operations. Q1 results were mixed but overall positive, in our view. We maintain our Hold recommendation on shares.